Society of Toxicology (SOT) 2026 Annual Meeting and ToxExpo

An exterior view of the San Diego Convention Center, host of the Society of Toxicology Annual Meeting (SOT) 2026, showcasing its iconic sail-like rooftop structures against a clear blue sky. The spacious plaza and palm trees in the foreground emphasize the vibrant and sunny atmosphere of the location.

Thank you for Joining Pharmaron at the SOT 2026 Annual Meeting and ToxExpo

March 22–25, 2026 | San Diego Convention Center

Pharmaron was proud to sponsor the 2026 Society of Toxicology Annual Meeting and ToxExpo in San Diego, CA as an exhibitor. The three-day ToxExpo took place March 23–25 from 9:00 AM to 4:30 PM, and brought together leading scientists, research organizations, government agencies, and industry partners dedicated to advancing toxicology and human health.

Our scientific leaders and business development teams were available at Booth #2134 to discuss your projects in depth. We enjoyed learning how our safety assessment and toxicology capabilities can support the development and regulatory success of your small molecules, biologics, cell and gene therapy products, and medical devices. If you missed us at SOT and still want to connect, fill out the meeting request below and our team will reach out to set a good time to meet with you.

Our SOT Annual Meeting and ToxExpo Schedule

Exhibit Hours

Exhibit Booth # 2134

  • March 23 – 25, from 9:00 am to 4:30 pm

Talks and Posters

Join our Exhibitor-Hosted Session

Pharmaron is proud to present our exhibitor-hosted session titled, “A Holistic Approach to Toxicology and Bioanalysis of ADCs”

  • Where: Room 23B
  • When: Tuesday, March 24th, from 9:15–10:15 AM
Schedule a Meeting Using the Form Below
Sheetal Desai
Sr. Director Business Development
Safety Assessment
Sandeep Kumar, Ph.D.,
Director of Ophthalmology

Pharmaron presented a holistic approach to ADC toxicology, integrating physicochemical and ADME insights to enable meaningful interpretation. We address in vivo toxicology in cynomolgus monkeys and the complexity of ADC bioanalysis using LC‑MS and LBA platforms, including hybrid and generic methods, to enable robust quantification during discovery and regulatory stages.

Schedule a Meeting Using the Form Below

Our Talk

Session 43, Visionary Foresight Symposium: Pioneering Cell-Based Therapies

  • When: Wednesday, March 25, 2026
  • Time: 8:00 -10:45 am
  • Speaker: Sandeep Kumar, Ph.D., Director of Ophthalmologywill speak in the Ocular Specialty Section; Biotechnology Specialty Section & Regulatory and Safety Evaluation Specialty Section.
  • Talk Title: Enabling Breakthroughs in Ocular Disease: The Strategic Role of CROs in Cell Therapy Development
  • Abstract: Cell-based therapies hold transformative potential for treating ocular diseases, offering innovative approaches for conditions that currently lack effective treatments. Their successful development, however, requires comprehensive and rigorous preclinical evaluation to ensure safety, efficacy, and alignment with regulatory expectations. Contract Research Organizations (CROs) play a pivotal role in supporting pharmaceutical and biotechnology sponsors throughout the nonclinical development pipeline. This presentation will highlight the strategic contributions of CROs in designing and executing ocular cell therapy studies that support safety and efficacy assessments—from early-stage planning through Investigational New Drug (IND)-enabling studies. Key focus areas include selecting appropriate and translational animal models, thorough characterization of the cell therapy product, precise surgical delivery techniques tailored for ocular administration, and advanced in vivo imaging modalities to monitor biodistribution, therapeutic effects and safety. The importance of adhering to Good Laboratory Practice (GLP) standards will also be discussed, as these are critical for ensuring data integrity, meeting regulatory requirements, and facilitating a smooth transition to first-in-human clinical trials.

Our Poster Presentations:

Monday, March 23, 2026

9:15 to 11:45 AM

Monday, March 23, 2026

1:45 to 4:15 PM

Tuesday, March 24, 2026

9:15 to 11:45 AM

Wednesday, March 25, 2026

9:15 to 11:45 AM

1:45 to 4:15 PM

See You Next Year!

About the Society of Toxicology Annual Meeting

The SOT Annual Meeting and ToxExpo is a unique gathering of 5,000+ toxicologists and industry professionals. With 70 scientific sessions, over 2,000 poster presentations, and 250 exhibitors, this premier event dives deep into cutting-edge science and technology in toxicology. But it’s more than just science—a vibrant forum for networking, mentorship, and career advancement, with approachable experts and a collaborative atmosphere where innovation thrives. Connect with Pharmaron’s team at Booth #1062 to discover how our safety assessment services can elevate your projects. Register today.

Request a Meeting

Learn More About Pharmaron‘s Services

Blurred image of a conference or trade show, featuring booths with colorful displays and attendees walking in the background, emphasizing the bustling and lively atmosphere of the event.

View Our Upcoming Events

Upcoming Events
Scientists in full cleanroom attire conduct radiolabelled ADME studies under a fume hood for drug safety assessment in a sterile lab environment.

Safety Assessment

Pharmaron’s experienced team evaluates the safety of new drug candidates from general toxicology, safety pharmacology, genetic toxicology, DART to immunotoxicity and immunogenicity in support of our partner’s IND and NDA submissions worldwide.
Learn about our Safety Assessments
Close-up of a microscope lens focused on glass slides, highlighting detailed sample analysis in a pathology lab setting.

Specialty Safety Assessment

Pharmaron’s special safety assessment services cover CGT, ocular and medical device products.
Learn about our Specialty Safety Assessments